IDH-Mutant Diffuse Glioma: From Metabolic Origins to Targeted Therapy
IDH-mutant diffuse gliomas exemplify precision neuro-oncology, in which a single metabolic alteration informs diagnosis, disease monitoring, and targeted therapeutic approach, and continue to define the role of IDH inhibition across different disease stages and in combination with immunotherapy and standard treatments.